These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1091976)

  • 61. Central nervous system involvement in pediatric rheumatic diseases: current concepts in treatment.
    Duzova A; Bakkaloglu A
    Curr Pharm Des; 2008; 14(13):1295-301. PubMed ID: 18537653
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Letter: Treatment of lupus erythematosus.
    Ann Intern Med; 1976 Mar; 84(3):337-8. PubMed ID: 1259271
    [No Abstract]   [Full Text] [Related]  

  • 63. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months.
    Decker JL; Klippel JH; Plotz PH; Steinberg AD
    Ann Intern Med; 1975 Nov; 83(5):606-15. PubMed ID: 1106278
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anti-P antibodies and neuropsychiatric lupus erythematosus.
    Georgescu L; Mevorach D; Arnett FC; Reveille JD; Elkon KB
    Ann N Y Acad Sci; 1997 Aug; 823():263-9. PubMed ID: 9292053
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Methotrexate therapy in childhood systemic lupus erythematosus.
    Abud-Mendoza C; Sturbaum AK; Vazquez-Compean R; Gonzalez-Amaro R
    J Rheumatol; 1993 Apr; 20(4):731-3. PubMed ID: 8496874
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Letter: Spleen size in SLE.
    Milder MS; Aptekar RG; Larson SM; Decker JL; Johnston GS
    Arthritis Rheum; 1974; 17(2):190-1. PubMed ID: 4592572
    [No Abstract]   [Full Text] [Related]  

  • 67. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
    Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA
    J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review.
    Henegar CE; Eudy AM; Kharat V; Hill DD; Bennett D; Haight B
    Lupus; 2016 May; 25(6):617-26. PubMed ID: 26743322
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus.
    Jarek MJ; West SG; Baker MR; Rak KM
    Arthritis Rheum; 1994 Nov; 37(11):1609-13. PubMed ID: 7980671
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Systemic lupus erythematosus and myoclonic epileptic manifestations.
    Mecarelli O; de Feo MR; Accornero N; Paffetti A
    Ital J Neurol Sci; 1999 Apr; 20(2):129-32. PubMed ID: 10933433
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.
    Ginzler E; Diamond H; Guttadauria M; Kaplan D
    Arthritis Rheum; 1976; 19(4):693-9. PubMed ID: 782464
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus].
    Lefèvre G; Zéphir H; Warembourg F; Michelin E; Pruvo JP; Hachulla E; Semah F; Dubucquoi S; Lenfant P; Vermersch P; Hatron PY; Prin L; Launay D
    Rev Med Interne; 2012 Sep; 33(9):491-502. PubMed ID: 22579860
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enteric-coated mycophenolate sodium versus azathioprine in patients with active systemic lupus erythematosus: a randomised clinical trial.
    Ordi-Ros J; Sáez-Comet L; Pérez-Conesa M; Vidal X; Mitjavila F; Castro Salomó A; Cuquet Pedragosa J; Ortiz-Santamaria V; Mauri Plana M; Cortés-Hernández J
    Ann Rheum Dis; 2017 Sep; 76(9):1575-1582. PubMed ID: 28450313
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunoglobulins in the larynx in systemic lupus erythematosus.
    Gilliam JN; Cheatum DE
    Arch Dermatol; 1973 Nov; 108(5):696-7. PubMed ID: 4127210
    [No Abstract]   [Full Text] [Related]  

  • 76. Current status of lupus nephritis.
    Jaryal A; Vikrant S
    Indian J Med Res; 2017 Feb; 145(2):167-178. PubMed ID: 28639592
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Arthritis rounds: Ascites as the major manifestation of systemic lupus erythematosus. Discussion.
    Ball EV
    Arthritis Rheum; 1976; 19(4):786. PubMed ID: 942509
    [No Abstract]   [Full Text] [Related]  

  • 78. [Disseminated lupus erythematosus without antinuclear antibodies or other autoantibodies].
    Duc J; Perroulaz G; Golaz J; Campiche M; Pécoud A
    Schweiz Med Wochenschr; 1987 Feb; 117(6):205-8. PubMed ID: 3494306
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lupus pneumonitis and anti-SSA(Ro) antibodies.
    Boulware DW; Hedgpeth MT
    J Rheumatol; 1989 Apr; 16(4):479-81. PubMed ID: 2664170
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
    Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
    Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.